Cybersecurity for the pharmaceutical and healthcare sectors has increased at a faster rate than other sectors, and protecting data and valuable trade secrets, has never been more important for life sciences companies.
Advancements in technology has created an increasing need for automation and robotics, remote access and factory-wide connectivity which has translated into significant change in pharmaceutical production and control systems in the last decade.
As with most industries, cybersecurity in the life sciences sector is only as good as the weakest link in terms of a company’s staff, processes, and technology.
So how should companies leverage the benefits of these new technologies while minimizing the security risks?
Join us and your executive peers, for a roundtable discussion over a cocktail and dinner hosted by Mike Towers, VP & CISO at Allergan, Rocco Grillo, NH-ISAC Advisory Board member and Executive Managing Director at Stroz Friedberg, and Rick Howard, CSO at Palo Alto Networks in NYC on the evening of June 27th to look at the significant changes in pharma and life sciences production and control systems in the last decade and the best way to address rising concerns.
Even if answers and solutions aren’t around the bend, let’s bring our industry experience and smarts to discuss some of the pressing questions;
- Production Risk: What IoT protections are working for you?
- Cyber Insurance as it applies to industry Risk; what works and what does not?
- Data Classification as a reduce-the-attack-surface best practice for protecting IP
- As a CISO are you empowered by senior leadership
- What are you telling the Board?
Audience: CISOs and CSOs in the Pharma, Biotech and Life sciences industries